H. Lundbeck A/S

General ticker "HLBBF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $5.8B (TTM average)

H. Lundbeck A/S follows the US Stock Market performance with the rate: 38.7%.

Estimated limits based on current volatility of 0.7%: low 6.86$, high 6.95$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2025-03-28, amount 0.14$ (Y2.05%)
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [5.29$, 8.33$]
  • 2025-12-31 to 2026-12-31 estimated range: [5.59$, 8.76$]

Financial Metrics affecting the HLBBF estimates:

  • Positive: with PPE of 12.3 at the end of fiscal year the price was very low
  • Positive: 7.86 < Operating profit margin, % of 14.86
  • Negative: negative Industry operating cash flow (median)
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.23
  • Positive: 6.82 < Operating cash flow per share per price, % of 8.34
  • Positive: Interest expense per share per price, % of 0.28 <= 0.79
  • Negative: negative Industry operating income (median)
  • Negative: Investing cash flow per share per price, % of -38.34 <= -14.38
  • Positive: Inventory ratio change, % of -2.86 <= -0.75
  • Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15

Similar symbols

Short-term HLBBF quotes

Long-term HLBBF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue DKK18,246.00MM DKK19,912.00MM DKK22,004.00MM
Operating Expenses DKK15,394.00MM DKK16,717.00MM DKK18,734.00MM
Operating Income DKK2,852.00MM DKK3,195.00MM DKK3,270.00MM
Non-Operating Income DKK-378.00MM DKK-202.00MM DKK449.00MM
Interest Expense DKK103.00MM DKK54.00MM DKK113.00MM
R&D Expense DKK3,754.00MM DKK3,457.00MM DKK4,501.00MM
Income(Loss) DKK2,474.00MM DKK2,993.00MM DKK3,719.00MM
Taxes DKK558.00MM DKK703.00MM DKK576.00MM
Profit(Loss)* DKK980.00MM DKK1,385.00MM DKK3,016.00MM
Stockholders Equity DKK20,779.00MM DKK22,045.00MM DKK25,010.00MM
Inventory DKK3,973.00MM DKK4,427.00MM DKK3,983.00MM
Assets DKK37,452.00MM DKK37,407.00MM DKK56,976.00MM
Operating Cash Flow DKK3,519.00MM DKK4,080.00MM DKK3,326.00MM
Capital expenditure DKK820.00MM DKK501.00MM DKK565.00MM
Investing Cash Flow DKK-1,892.00MM DKK-498.00MM DKK-15,286.00MM
Financing Cash Flow DKK-387.00MM DKK-2,085.00MM DKK11,629.00MM
Earnings Per Share** DKK0.99 DKK1.40 DKK3.04

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.